← Back to Sai Life Sciences Ltd. overview
Sai Life Sciences Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹1,660 cr | ₹170 cr | ₹8.61 | ₹3,160 cr | ₹2,128 cr | 7.99% | 12.25% | 0.17x | 10.25% |
| FY2024 | ₹1,456 cr | ₹83 cr | ₹3.98 | ₹2,275 cr | ₹975 cr | 8.49% | 10.26% | 0.95x | 5.69% |
| FY2023 | ₹1,197 cr | ₹10 cr | ₹0.48 | ₹2,187 cr | ₹888 cr | 1.12% | 5.13% | 1.05x | 0.83% |
| FY2022 | ₹869 cr | ₹6 cr | ₹0.3 | ₹2,164 cr | ₹879 cr | 0.71% | 3.21% | 1.1x | 0.72% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.